Letter to the Editor on Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid

We had the opportunity to read last issue’s article by Sharfman et al [1] regarding the use of an intermittent pneumatic compression device (IPCD) and tranexamic acid (TXA) as prophylactic measures against venous thromboembolic disease and bleeding, respectively. The authors’ research on the subject...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2016

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/26364

Acceso en línea:

https://doi.org/10.1016/j.arth.2016.06.041
https://repository.urosario.edu.co/handle/10336/26364

Palabra clave:

Enoxaparin
Tranexamic acid
Anticoagulant agent
Tranexamic acid
Bleeding
Blood donor
Blood transfusion
Chemoprophylaxis
Drug efficacy
Gold standard
Human
Intermittent pneumatic compression device
Letter
Practice guideline
Preoperative period
Thrombosis prevention
Total hip prosthesis
Total knee arthroplasty
Venous thromboembolism
Arthroplasty
Bleeding
Knee replacement
Venous thromboembolism
Anticoagulants
Arthroplasty
Arthroplasty
replacement
knee
Enoxaparin
Hemorrhage
Humans
Tranexamic acid
Venous thromboembolism

Rights

License

Abierto (Texto Completo)